Five Year Prostate-specific Antigen Outcomes after Caesium Prostate Brachytherapy

Clinical Oncology

August 5, 2014

Related posts

Clinical Outcomes of a Phase II, Multi-Institutional Cesium-131 Premanent Prostate Brachytherapy Trial

Authors: B. Prestidge

Cs-131 Prostate Brachytherapy and Treatment Plan Parameters

Authors: Sutlief S and Wallner K

Is Cs-131 or I-125 or Pd-103 the “Ideal” Isotope for Prostate Boost Brachytherapy?–A Dosimetric View Point

Authors: R. Yaparpalvi, J. Rossinow, W.A. Cavanagh, W. Choi1, L. Minsky, N. Kahan1, W. Bodner, M. Garg, S. Kalnicki, C. Guha

Is there Decreased Duration of Acute Urinary and Bowel Symptoms after Prostate Brachytherapy with Cesium 131 Radioisotope?

Authors: S.G. DeFoe, S. Beriwal, R. Smith, R. Benoit

Company

Brachytherapy

Theranostics

Newsletter

Want to keep up-to-date on news and information?

Company

Newsletter

Want to keep up-to-date on news and information?

©2023. All rights reserved. Terms & Privacy | Privacy Policy

Scroll to top